1
Patients with leukopenia should be considered as recipients of prophylaxis for relapse.
2
The major dose-limiting toxic effect for all three agents was leukopenia.
3
Cycle delays due to leukopenia were similar in both arms of the study.
4
High-dose uridine given as intermittent intravenous infusions was feasible and reversed 5-FU-induced leukopenia.
5
Lithium administration has been shown to attenuate the leukopenia associated with systemic chemotherapy.
1
The platelets were decreased, serum liver enzymes were increased and leucopenia was seen.
2
Six patients required discontinuation of medication, two because of leucopenia.
3
In association with the leucopenia and the oropharyngeal lesions, a variety of other infective processes were seen.
4
Investigations showed that that the patient had leucopenia, positive antinuclear and anti-double-stranded DNA antibodies and lupus nephritis.
5
This regimen was associated with severe hematological toxicity, mainly leucopenia; five toxic deaths related to sepsis were observed.
1
Toxicity was mainly hematologic, with leukocytopenia being the most frequent cause of treatment delay.
2
We found that TM208 significantly inhibited tumor growth but did not cause loss of body weight or leukocytopenia.
3
Major toxicity was leukocytopenia and 64% and 80% of patients encountered leukocytopenia of Grade 3 or 4.